Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Cancer Incidences (Million), 2015-2022
Figure 3-2: Cancer Mortality (Million), 2015-2022
Figure 3-3: Incidences by Type of Cancer (%), 2016
Figure 3-4: States with Highest Cancer Incidences, 2015
Figure 5-1: Share of US in Global Cancer Vaccine Market (%), 2016
Figure 5-2: US - Cancer Vaccine Market by Product Type (%), 2016
Figure 5-3: Global - Provenge Market (Million US$), 2013-2015
Figure 5-4: Share of US in Global Imlygic Sales (%), 2015
Figure 5-5: Global - Gardasil Market (Million US$), 2013-2015
Figure 5-6: US - Gardasil Market (Million US$), 2013-2015
Figure 5-7: Share of US in Global Gardasil Sales (%), 2015
Figure 5-8: Global - Cervarix Market (Million US$), 2013-2015
Figure 5-9: US - Cervarix Market (Million US$), 2013-2015
Figure 5-10: Share of US in Global Cervarix Sales (%), 2015
Figure 5-11: Global - Engerix-B Market (Million US$), 2013-2015
Figure 5-12: US - Engerix-B Market (Million US$), 2013-2015
Figure 5-13: Share of US in Global Engerix-B Sales (%), 2015
Figure 5-14: Global - Recombivax HB Market (Million US$), 2013-2015
Figure 5-15: US - Recombivax HB Market (Million US$), 2013-2015
Figure 5-16: Share of US in Global Recombivax HB Sales (%), 2015
Figure 5-17: Global - Pediarix/Infanrix Market (Million US$), 2013-2015
Figure 5-18: US - Pediarix/ Infanrix Market (Million US$), 2013-2015
Figure 5-19:  Share of US in Global Pediarix/Infanrix Sales (%), 2015
Figure 6-1: US - Cancer Vaccine Market by Cancer Type (%), 2016
Figure 6-2: US - Cancer Vaccine Market for Liver Cancer (Million US$), 2015-2022
Figure 6-3: US - Cancer Vaccine Market for HPV Related Cancer (Million US$), 2015-2022
Figure 6-4: US - Cancer Vaccine Market for Other Cancers (Million US$), 2015-2022
Figure 7-1: US - Cancer Vaccine Market by Application (%), 2016
Figure 7-2: US - Cancer Vaccine Market for Therapeutic Vaccines (Million US$), 2015-2022
Figure 7-3: US - Cancer Vaccine Market for Prophylactic Vaccines (Million US$), 2015-2022
Figure 8-1: Prophylactic Cancer Vaccines in Clinical Trials by Cancer Site (%), 2016
Figure 8-2: Prophylactic Cancer Vaccines in Clinical Trials by Phases (%), 2016
Figure 8-3: Therapeutic Cancer Vaccines in Clinical Trials by Cancer Site (%), 2016
Figure 8-4: Therapeutic Cancer Vaccines in Clinical Trials by Phases (%), 2016
Figure 8-5: Cancer Vaccines in Clinical Trials by Application (%), 2016
Figure 11-1: US - Share of Major Players in Cancer Vaccine Market (%), 2015
Figure 12-1: Merck & Co. - Breakup of Revenue by Segment (%), 2015
Figure 12-2: GlaxoSmithKline - Breakup of Revenue by Segment (%), 2015
Figure 12-3: Valeant Pharmaceuticals International, Inc. - Breakup of Revenue by Segment (%), 2015
 
List of Tables:

Table 3-1: Top 10 Cancer Incidences in Males (2015)
Table 3-2: Top 10 Cancer Incidences in Females (2015)
Table 3-3: Top 10 Cancer Incidences in Children (Ages 0-14), (2015)
Table 4-1: US - Cancer Incidences (Million), 2015 & 2020
Table 5-1: Global - Cancer Vaccine Market (Million US$), 2015-2022
Table 5-2: US - Cancer Vaccine Market (Million US$), 2015-2022
Table 8-1: Cancers with High Linkage to Virus and Bacteria
Table 8-2: Prophylactic Cancer Vaccines in Clinical Trials
Table 8-3: Therapeutic Cancer Vaccines in Clinical Trials
Table 8-4: Prostate Cancer Therapeutic Vaccines in Clinical Trials
Table 8-5: Breast Cancer Therapeutic Vaccines in Clinical Trials
Table 8-6: Lung Cancer Therapeutic Vaccines in Clinical Trials
Table 8-7: Colorectal Cancer Therapeutic Vaccines in Clinical Trials
Table 12-1: Merck & Co. - Key Financials (Million US$), 2013-2015
Table 12-2: Merck - Product Portfolio
Table 12-3: Merck - Cancer Vaccines in Pipeline
Table 12-4: GlaxoSmithKline - Key Financials (Million US$), 2013-2015
Table 12-5: GlaxoSmithKline - Product Portfolio
Table 12-6: GlaxoSmithKline - Cancer Vaccines in Pipeline
Table 12-7: Valeant Pharmaceuticals International, Inc. - Key Financials (Million US$), 2013-2015
Table 12-8: Dendreon - Product Portfolio
Table 12-9: Amgen Inc. - Key Financials (Million US$), 2013-2015
Table 12-10: Amgen Inc. - Product Portfolio